Rare diseases
Investigational molecules
Locations
Back to Germany62 clinical trials in Ravensburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
GermanyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
GermanyStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
GermanyStudy of zanidatamab with drug combination for patients with HER2 and PD-L1 positive advanced gastroesophageal cancer
GermanyStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
GermanyStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
GermanyStudy of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib
GermanyStudy on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy
GermanyStudy on Fruquintinib and Tislelizumab for Patients with Metastatic Colorectal Cancer Without Liver Metastases
GermanyStudy on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
GermanyComparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel
GermanyStudy on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, evaluating innovative therapeutic combinations and targeted approaches.
Studies examining novel drug combinations including ribociclib, abemaciclib, and innovative targeted therapies.
Groundbreaking research in chronic lymphocytic leukemia (CLL) and lymphomas, investigating new treatment protocols and drug combinations.
Focus on venetoclax combinations and novel therapeutic approaches for elderly and frail patients.
Advanced research in ovarian cancer and endometrial cancer, exploring innovative treatment combinations and targeted therapies.
Studies evaluating niraparib, dostarlimab, and other targeted therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
